Please assess the completion status of the following clinical trial:

Trial Title: Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men undergoing an outpatient prostate biopsy independently indicated by a physician.~* Patients will be selected from the population initially studied with a prostate biopsy for possible prostate cancer~  * sub-group without evidence of cancer~ * sub-group with advanced prostate cancer beyond the currently accepted criteria for surgical treatment,~ * sub-group with indication of radical prostatectomy~* Patients will be recruited from the population of patients from Brigham and Women's Hospital for surgery referred from other institutions/doctors where their biopsy was taken and the diagnosis of prostate cancer was originally made. These patients are not eligible for Aim 1 but will enter the randomized trial (Aim 2 with baseline)~Exclusion Criteria:~* Prostate biopsy patients who do not accept and sign an informed consent form to~  * donate ten ml of blood for fatty acid analysis in red blood cells~ * allow their prostate biopsy to be analyzed as discarded pathological material~ * authorize access to their hospital clinical information for follow up studies~* Patients with a current diagnosis of a condition that might interfere with the measurements of fatty acids in red blood cell membranes such as severe anemia (less than 9g/100m1% hemoglobin~  -- Or~* Diseases of lipid metabolism such as familial dyslipoproteinemia, liver cirrhosis, advanced renal failure, and malabsorption syndrome.~* Exclude from this study patients from (indication of radical prostatectomy) who refuse the surgical recommendation or schedule surgery at a location other than Brigham and Women's Hospital.~* Patients who are not able to complete the full program will not be taken into consideration in the final data analysis.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 120 Years
- Healthy Volunteers: f

Study Arms:
- omega-3 fatty acids (Type: EXPERIMENTAL): omega-3 fatty acids Oral 8g once a day for 21 days prior to (biopsy) surgery
- Corn Oil (Type: PLACEBO_COMPARATOR): Oral 8g once a day for 21 days prior to (biopsy) surgery

Based on this trial design, predict the completion outcome and termination type (if applicable).